GHK-Cu Research Guide
Longevity and tissue research peptide
GHK-Cu is a naturally occurring tripeptide-copper complex first isolated from human plasma in 1973. Across five decades of research it has emerged as one of the most studied skin and tissue remodeling peptides, with a documented gene-expression profile that resets thousands of human genes toward a more youthful state.
Contents
|
Tripeptide + Cu(II) Glycyl-Histidyl-Lysine |
Gene expression 4,000+ genes modulated |
1973 First isolated |
What is GHK-Cu?
GHK-Cu is the copper-bound form of the tripeptide glycyl-L-histidyl-L-lysine, naturally present in human plasma at concentrations that decline measurably with age. The peptide was first isolated by Loren Pickart in 1973 during studies of human plasma activity that promoted liver regeneration in older animal tissue.
The defining feature of GHK-Cu in research is its ability to bind copper ions (Cu²⁺) with extremely high affinity. The resulting complex shuttles bioavailable copper into cells, where it influences enzyme activity, gene expression, and tissue remodeling pathways that are otherwise difficult to access through dietary copper alone.
Aeternum Labs supplies GHK-Cu as a lyophilized powder verified to 99%+ purity by HPLC, with mass spectrometry confirmation of the copper-bound complex and full Certificate of Analysis published in the public COA library.
Mechanism of action
The most striking research finding on GHK-Cu is its broad gene-expression-resetting activity. Microarray studies by Pickart and colleagues have shown that GHK-Cu modulates expression of more than four thousand human genes, with the net pattern shifting expression toward profiles characteristic of younger tissue across multiple cell types.
Tissue remodeling effects are mediated through stimulation of collagen, elastin, and glycosaminoglycan synthesis in dermal fibroblasts. GHK-Cu also upregulates matrix metalloproteinases that break down damaged extracellular matrix, while simultaneously promoting synthesis of fresh ECM components — a coordinated remodeling rather than pure stimulation.
Copper delivery to cells supports activity of copper-dependent enzymes including superoxide dismutase (antioxidant defense), lysyl oxidase (collagen crosslinking), and cytochrome c oxidase (mitochondrial respiration). The integrated effect on these copper-dependent systems contributes to the broad cellular and tissue effects observed in the research literature.
Research history
GHK was first identified by Loren Pickart in 1973 during studies of why human plasma from younger donors restored liver function in older rat tissue more effectively than plasma from older donors. The active component was identified as the tripeptide glycyl-histidyl-lysine.
Subsequent research established the copper-binding affinity of GHK and characterized the GHK-Cu complex as the biologically active form. The 1980s and 1990s produced the foundational dermatology research, including studies of wound healing acceleration and reduction of scar formation.
The 2010s brought the gene-expression research wave, with broad microarray studies establishing GHK-Cu’s effect on thousands of genes simultaneously. This shifted the research framing from ‘wound healing peptide’ to ‘gene expression modulator with anti-aging implications,’ which is the dominant frame in current research.
Half-life and pharmacokinetics
GHK-Cu is administered in research via subcutaneous injection, topical application, or intranasal routes depending on the target tissue. Topical application is well-documented in dermatology research. Subcutaneous administration produces systemic exposure suitable for studies of broader tissue effects.
Plasma half-life of administered GHK-Cu is short due to rapid tissue distribution and uptake. The cellular half-life of effects is much longer because of the gene-expression mechanism, where transcriptional changes persist for days to weeks after exposure ceases.
Typical research doses
Topical research dose ranges in dermatology studies span 0.1% to 5% concentrations applied once or twice daily. Wound healing acceleration is observed in this range with the higher concentrations producing more pronounced effects in matched study designs.
Subcutaneous research dose ranges span approximately 1 mg to 5 mg per administration, with frequencies from daily to twice-weekly depending on the endpoint studied. Longevity-oriented research protocols tend to use lower doses with more frequent administration.
Compliance reminder
All dose ranges discussed are reported from peer-reviewed in vitro and animal research. They are not human-use dose recommendations.
Reconstitution protocol
Lyophilized peptides require reconstitution with a sterile solvent before any in vitro work. The standard solvent across virtually all research-peptide protocols is bacteriostatic water (sterile water with 0.9% benzyl alcohol), which prevents microbial growth across the typical four-week working window once a vial is opened.
Add the solvent slowly down the inside wall of the vial rather than directly onto the lyophilized cake. Swirl gently until the powder dissolves fully. Do not shake — agitation can denature peptide bonds and reduce assay potency. A clear, particle-free solution should result within thirty to sixty seconds.
Volume calculations are straightforward. For a 10 mg vial reconstituted with 2 mL of bacteriostatic water, each 0.1 mL of the resulting solution contains 0.5 mg of peptide. Researchers planning multi-week protocols should compute their volumes ahead of time and document the lot number against each preparation.
Storage and stability
Sealed lyophilized vials are stable at 0°F (−18°C) for up to twenty-four months in most research literature. Vials should be kept dry, light-protected, and away from temperature fluctuations. Avoid storing peptides in the freezer door, where each open-close cycle introduces thermal stress.
Once reconstituted, store the working solution at 36–46°F (2–8°C). Most lyophilized peptides remain stable in solution for twenty-eight days under refrigeration with bacteriostatic water as the diluent. For protocols longer than four weeks, reconstitute fresh batches as needed rather than extending a single working vial.
Repeated freeze-thaw cycles reduce peptide integrity. If long-term storage of a reconstituted sample is required, aliquot the solution into single-use volumes before freezing so each thaw uses a fresh aliquot.
GHK-Cu solutions can develop a faint blue tint due to the copper coordination — this is normal and does not indicate degradation. Light-protected storage extends working solution stability.
Common stack pairings
GHK-Cu + BPC-157 (skin and tissue research)
BPC-157’s VEGF-mediated angiogenesis combined with GHK-Cu’s gene-expression and remodeling effects produces a multi-mechanism approach to dermal and tissue research endpoints.
GHK-Cu + NAD+ (longevity research)
NAD+ supports mitochondrial function and sirtuin activity. Combined with GHK-Cu’s gene-expression resetting, this stack is researched for cellular and tissue rejuvenation endpoints in aging-related research models.
How it compares
Compared to BPC-157: BPC-157 acts primarily through VEGF and nitric oxide synthase pathways with broad tissue applicability. GHK-Cu acts through gene expression modulation and copper delivery, with particular strength in dermal and longevity research.
Compared to other anti-aging peptides: GHK-Cu’s distinguishing feature is its broad gene-expression effect across thousands of genes simultaneously, which is unusual for a small peptide. Most other anti-aging compounds target single pathways.
From the Aeternum library
GHK-Cu
- 99%+ purity verified by HPLC
- Mass spec confirmation of Cu(II) complex
- LAL endotoxin screening
- Full Certificate of Analysis published
- Lyophilized powder
Frequently asked questions
What does the 'Cu' in GHK-Cu stand for?
Cu is the chemical symbol for copper. GHK-Cu is the copper-bound form of the tripeptide glycyl-histidyl-lysine, where the copper ion (Cu²⁺) is the biologically active configuration that delivers copper into cells and modulates gene expression.
How does GHK-Cu modulate so many genes at once?
The exact mechanism is still being characterized, but appears to involve a combination of direct effects on transcription factor activity, modulation of chromatin accessibility through copper delivery to chromatin-modifying enzymes, and downstream cascade effects from the initial transcriptional shifts. The net effect documented in microarray studies is modulation of more than four thousand human genes.
Can GHK-Cu be applied topically?
Yes. Topical application is well-documented in dermatology research, with concentration ranges from 0.1% to 5% in published studies. Topical use is most relevant for skin and wound research endpoints.
Why does my GHK-Cu solution look slightly blue?
This is normal and reflects the copper coordination in the complex. The faint blue tint is a feature of the active GHK-Cu molecule and not a sign of degradation. Light-protected storage helps maintain working solution stability.
What dose ranges are used in research?
Topical research uses 0.1–5% concentrations once or twice daily. Subcutaneous research uses approximately 1–5 mg per administration with frequencies from daily to twice-weekly depending on the endpoint studied.
References
- Pickart L, Margolina A (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. View source
- Pickart L, Vasquez-Soltero JM, Margolina A (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. View source
- Hong Y, Downey T, Eu KW, Koh PK, Cheah PY (2010). A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. View source
- Pickart L (2008). The human tri-peptide GHK and tissue remodeling. View source
Reviewed by
The Aeternum Labs Research Team
Compounds, COAs, and protocol design
The Aeternum Labs research team verifies every batch in our library against published purity and identity standards. Articles in our research blog summarize publicly available scientific literature and are reviewed for accuracy by team members trained in peptide biochemistry and laboratory protocol design.
Related research
Category
Best peptides for longevity research →
Category
Best peptides for skin research →
Pair with
NAD+ research guide →
Pair with
BPC-157 research guide →
Research Disclaimer. All compounds discussed in this article are sold by Aeternum Labs for in vitro laboratory research purposes only. They are not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease or condition. Information presented is summarized from publicly available scientific literature and should not be construed as medical advice.